Breast Cancer Clinical Trials

Showing 781-800 of 4,817 trials

Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.

NCT06364267

The purpose of the study is to to compare low dose of exemestane (babyexe) versus low dose of tamoxifen (babytam) in terms of change of quality of life from baseline to 12 months.

Breast Cancer

Andrea DeCensi140 participantsStarted Oct 2025

Genova, Italy, Italy

Active Not RecruitingPhase 2

MARGetuximab Or Trastuzumab (MARGOT)

NCT04425018

The purpose of this study is to determine how well participants with stage II-III HER2-positive breast cancer respond to pre-operative treatment using one of two different combinations of drugs. Drugs and Combinations used: * Paclitaxel, Pertzumab and Margetuximab (Margenza) * Paclitaxel, Pertzumab and Trastuzumab (Herceptin)

Breast CancerStage II Breast CancerStage III Breast Cancer+1 more

Dana-Farber Cancer Institute174 participantsStarted Jul 2020

Washington D.C., District of Columbia, United States • Washington D.C., District of Columbia, United States • Boston, Massachusetts, United States +11 more locations

Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.

MARGetuximab Or Trastuzumab (MARGOT)

Related Searches

Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

A Study to Learn More About Tukysa Once it is Out in the Korean Market

Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction

Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

Prediction of Long-term Arm Morbidity Following Breast Cancer Surgeries and Treatments

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer

A Study of PF-06873600 in People With Cancer

Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors

Developing Screening Clinical Breast Examination Implementation Strategies in Nigeria

A Study of LY3484356 in Women With Breast Cancer Before Having Surgery

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants

Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer

Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)